Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on: April 07,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on:April 07,2024

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on: February 23,2024

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on:February 23,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on: January 22,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on:January 22,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on: April 18,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on:April 18,2024

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on: January 12,2024

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on:January 12,2024

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga

Updated on: May 27,2024

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga

Updated on:May 27,2024

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a

Updated on: June 19,2024

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a

Updated on:June 19,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on: November 10,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on:November 10,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on: February 20,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on:February 20,2024

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d

Updated on: March 28,2024

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d

Updated on:March 28,2024